María Angeles Pérez Saenz

ACTIVIDAD CLINICA DE PREFERENCIA EN CONSULTA EXTERNA

INVESTIGACION EN CONTEXTO DE ENSAYOS CLINICOS

1- Civallero M, Schroers-Martin JG, Horwitz S, Manni M, Stepanishyna Y, Cabrera ME, Vose J, Spina M, Hitz F, Nagler A, Montoto S, Chiattone C, Skrypets T, Perez Saenz MA, Priolo G, Luminari S, Lymboussaki A, Pavlovsky A, Marino D, Liberati M, Trotman J, Mannina D, Federico M, Advani R. Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project. Br J Haematol. 2024 Jul;205(1):166-174. doi: 10.1111/bjh.19433. Epub 2024 Mar 26

2-Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy. López-Nevado M, Ortiz-Martín J, Serrano C, Pérez-Saez MA, López-Lorenzo JL, Gil-Etayo FJ, Rodríguez-Frías E, Cabrera-Marante O, Morales-Pérez P, Rodríguez-Pinilla MS, Manso R, Salgado-Sánchez RN, Cerdá-Montagud A, Quesada-Espinosa JF, Gómez-Rodríguez MJ, Paz-Artal E, Muñoz-Calleja C, Arranz-Sáez R, Allende LM.J Clin Immunol. 2023 Jan;43(1):165-180. doi: 10.1007/s10875-022-01361-y. Epub 2022 Sep 6.PMID: 36066697

3-Feasibility of Telemedicine in the Management Strategy of Patients With Lymphoma Amid the COVID-19 Pandemic in Spain: Prospective Observational Study. Cordoba R, Lopez-Garcia A, Morillo D, Perez-Saenz MA, Askari E, Prieto RE, Castillo Bazan E, Llamas Sillero P, Herrero Gonzalez A, Short Apellaniz J, Del Olmo M, Arcos J.JMIR Form Res. 2023 Nov 17;7:e34128. doi: 10.2196/34128

4-Pérez-Sáenz MA; Rodriguez-Pinilla MS; Salgado RN;Alonso-Dominguez JM. 2020. Three monocytic neoplasms in a single patient LeukLymphoma.61-10, pp.2523-2526

5- Santonja C; Carrasco L; Perez-Saenz MLA; Loreto Carrasco; Rodriguez-Pinilla SM. 2020. A Skin Plaque Preceding Systemic Relapse of Gamma-Delta Hepatosplenic T-Cell Lymphoma.Am J Dermatopathol. 42-5, pp.364-367.

6- Santonja C. 2020. -T-Cell-Rich Recurrence of Primary Cutaneous Follicle Center Lymphoma After Systemic Rituximab Am J Dermatopathol. 42-3, pp.36-40.

7- Manso R; Roncador G; Montes-Moreno S; Rojo F; Pérez-Saenz MA; Rodriguez-Pinilla MS. 2017. -p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients Br J Haematol. 176-4, pp.661-664.

8- Gomez-Leon N; Delgado-Bolton R; Cabezas B; Campo del Val L; Arranz R; Cannata J; Perez-Saenz MA; Gonzalez-Ortega S. 2017. Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi–Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma Clin Nuc Med. 42, pp.595-602.

9-Plaza C; Yuste M; Zheng B; Pérez-Saenz MA. Diffuse large B cell Lymphoma: On overview of the disease with especial focus on CIRS scale and Emergency visits in the elderly population.J Geriatr Oncolo. 7-6, pp.559.